Sonabend AM - Search Results

1

Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.

El Andaloussi A, Sonabend AM, Han Y, Lesniak MS. El Andaloussi A, et al. Among authors: sonabend am. Glia. 2006 Nov 1;54(6):526-35. doi: 10.1002/glia.20401. Glia. 2006. PMID: 16906541

2

Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.

Sonabend AM, Lesniak MS. Sonabend AM, et al. Expert Rev Neurother. 2005 Nov;5(6 Suppl):S25-32. doi: 10.1586/14737175.5.6.S25. Expert Rev Neurother. 2005. PMID: 16274268 Review.

3

Conditionally replicative adenoviral vectors for malignant glioma.

Sonabend AM, Ulasov IV, Lesniak MS. Sonabend AM, et al. Rev Med Virol. 2006 Mar-Apr;16(2):99-115. doi: 10.1002/rmv.490. Rev Med Virol. 2006. PMID: 16416455 Review.

4

Oncolytic adenoviral therapy for glioblastoma multiforme.

Sonabend AM, Ulasov IV, Han Y, Lesniak MS. Sonabend AM, et al. Neurosurg Focus. 2006 Apr 15;20(4):E19. Neurosurg Focus. 2006. PMID: 16709024 Review.

5

Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.

Tyler MA, Ulasov IV, Borovjagin A, Sonabend AM, Khramtsov A, Han Y, Dent P, Fisher PB, Curiel DT, Lesniak MS. Tyler MA, et al. Among authors: sonabend am. Mol Cancer Ther. 2006 Sep;5(9):2408-16. doi: 10.1158/1535-7163.MCT-06-0187. Mol Cancer Ther. 2006. PMID: 16985075

6

Oncogenesis and mutagenesis of pituitary tumors.

Sonabend AM, Musleh W, Lesniak MS. Sonabend AM, et al. Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S3-14. doi: 10.1586/14737140.6.9s.S3. Expert Rev Anticancer Ther. 2006. PMID: 17004855 Review.

7

Role of craniotomy in the management of pituitary adenomas and sellar/parasellar tumors.

Musleh W, Sonabend AM, Lesniak MS. Musleh W, et al. Among authors: sonabend am. Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S79-83. doi: 10.1586/14737140.6.9s.S79. Expert Rev Anticancer Ther. 2006. PMID: 17004861 Review.

8

Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.

Ulasov IV, Rivera AA, Sonabend AM, Rivera LB, Wang M, Zhu ZB, Lesniak MS. Ulasov IV, et al. Among authors: sonabend am. Cancer Biol Ther. 2007 May;6(5):679-85. doi: 10.4161/cbt.6.5.3957. Epub 2007 Feb 3. Cancer Biol Ther. 2007. PMID: 17404502 Free article.

9

Gene therapy trials for the treatment of high-grade gliomas.

Sonabend AM, Ulasov IV, Lesniak MS. Sonabend AM, et al. Gene Ther Mol Biol. 2007;11(A):79-92. Gene Ther Mol Biol. 2007. PMID: 17625614 Free PMC article.

10

An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.

Ulasov IV, Rivera AA, Nettelbeck DM, Rivera LB, Mathis JM, Sonabend AM, Tyler M, Wang M, Douglas JT, Lesniak MS. Ulasov IV, et al. Among authors: sonabend am. Int J Oncol. 2007 Nov;31(5):1177-85. Int J Oncol. 2007. PMID: 17912445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters